In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer early ...

Studying the chemical signatures of DNA fragments in the blood could help scientists pinpoint the cause of organ damage ...

Cell-free DNA (cfDNA) analysis is transforming precision medicine, offering a non-invasive window into the body, particularly in the context of cancer. This journal collection, hosted by npj ...

DNA methylation is one of the ways in which cells organize distinct identities despite inheriting the same genome.

New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology careiMDx sponsoring GraftAssureIQ research-use-only kits at transplant labs globallyExhibitin ...

Natera, Inc. shows strong revenue growth with Medicare-backed Signatera, but faces litigation risks and valuation challenges.

The other, called ARTEMIS-DELFI (tumor-independent genome-wide cfDNA fragmentation profiles ... to scan millions of cell-free DNA fragments only in the patient's blood samples.